A new drug from Northwestern University shrinks an incurable form of brain cancer in mice, paving the way for a possible therapy for this devastating disease.
Due to their seclusion, buried deep within fragile cerebral tissue and locked behind the fortress that is the skull, brain tumors are often tough to remove by surgery and other standard methods of cancer therapy.
This dearth of a good remedy is especially poignant for glioblastoma multiforme (GM), a highly aggressive brain tumor that grows quickly and can reach an enormous size before developing symptoms. All cancers are caused by gene mutations, and the researchers devised a cutting-edge strategy to target the ones responsible for the aggressive growth of glioblastoma tumors.
Read the full, original story here: Scientists Shrink Brain Cancer With Novel Gene Regulation Technology
